Could umbilical cord stem cells ease muscle weakness in FSHD?
NCT ID NCT07086521
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests whether stem cells from umbilical cord lining can safely help people with FSHD, a genetic muscle-weakening disease. Sixteen adults will receive two doses of the cells and two doses of a placebo (saline) through an IV, in random order. The main goal is to check safety and see if symptoms improve.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford Neuroscience Health Center
RECRUITINGPalo Alto, California, 94304, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Inflammation may be key in rare muscle disease
- FSHD patients unite: new registry aims to accelerate research and care
- FSHD drug trial halted midway: what happened?
- Experimental drug losmapimod tested for rare muscle disease
- New study aims to design better braces for FSHD patients using MRI and motion capture
- Hope for FSHD: new drug enters final stage of testing